Recommendation applies across England and Wales and the treatment is available now
News
VYNE and Tay Therapeutics reach licence agreement
Deal involves an oral BET inhibitor which treats fibrotic and immuno-inflammatory disorders
SporeGen and Destiny advance research collaboration
Duo have partnered on developing a biotherapeutic therapy for flu and COVID-19
NICE approves expanded use of Yescarta and Tecartus
Kite’s two CAR T-Cell therapies involve treating several different types of blood cancer
Positive CHMP opinion for UCB’s bimekizumab
Therapy concerns the treatment of adults with axial spondyloarthritis and psoriatic arthritis
King’s College London and Grünenthal join forces to ease pain
Duo will collaborate to develop pluripotent stem cell-based microfluidic cultures for pain research
Amphera and Alligator Bioscience reveal mitazalimab-MesoPher update
Therapy is being used during pivotal phase 1 study into patients with pancreatic cancer
Mainz Biomed in collaboration with Instituto de Microecologia
Vital link-up aims to expand ColoAlert detection tests in Europe and increase early cancer diagnosis
NICE approval for Janssen’s Darzalex combination
Recommendation concerns routine use across the NHS as therapy for multiple myeloma
Sanofi releases AVAXIM Junior in the UK
Therapy provides immunisation against infection caused by hepatitis A in children aged 12 months to 15 years
King’s College London reaches data agreement with PrecisionLife
The link-up will enable the company to identify new motor neurone disease biomarkers
Medigene reveals pivotal blood cancer therapy data
MDG1011 is a therapy which aims to improve outcomes for in patients with high-risk blood cancers
Janssen reaches Akeega approval milestone
Treatment involves the treatment of adults with metastatic castration-resistant prostate cancer
Shared vision for Boehringer Ingelheim and RetinAI
Companies will collaborate to boost novel treatments for individuals with geographic atrophy
AbbVie reveals results from pivotal atogepant trial
Study has been focusing on atogepant for the prevention of episodic migraine attacks
